World's Best Scientists 2026 revealed!
VIEW LIST
Anthony W. Tolcher

Anthony W. Tolcher

Texas Oncology
United States

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 86 14005 13188 7106 6579 699 30874

Anthony W. Tolcher publications per year

The chart shows the history of publications by Anthony W. Tolcher between 1987 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Anthony W. Tolcher published across 40 years, from 1987 to 2026, averaging 27.4 papers a year. Output peaked at 280 publications in 2023. 58 of the 1,097 publications appeared in the last two years.

No. of publications
50 100 150 200 250
Bar chart. Horizontal axis: year, 1987 to 2026. Vertical axis: number of publications, 0 to 280. Peak 280 publications in 2023. 1987: 1 publication 1988: 0 publications 1989: 0 publications 1990: 0 publications 1991: 0 publications 1992: 0 publications 1993: 0 publications 1994: 1 publication 1995: 3 publications 1996: 4 publications 1997: 3 publications 1998: 3 publications 1999: 8 publications 2000: 5 publications 2001: 10 publications 2002: 4 publications 2003: 10 publications 2004: 34 publications 2005: 22 publications 2006: 32 publications 2007: 26 publications 2008: 25 publications 2009: 28 publications 2010: 37 publications 2011: 43 publications 2012: 34 publications 2013: 41 publications 2014: 33 publications 2015: 38 publications 2016: 35 publications 2017: 30 publications 2018: 27 publications 2019: 16 publications 2020: 22 publications 2021: 28 publications 2022: 31 publications 2023: 280 publications 2024: 125 publications 2025: 55 publications 2026: 3 publications
1987 2026

1,097 publications in total across all disciplines

View publications per year as a table
Anthony W. Tolcher: publications per year, 1987 to 2026
Year Publications
1987 1
1988 0
1989 0
1990 0
1991 0
1992 0
1993 0
1994 1
1995 3
1996 4
1997 3
1998 3
1999 8
2000 5
2001 10
2002 4
2003 10
2004 34
2005 22
2006 32
2007 26
2008 25
2009 28
2010 37
2011 43
2012 34
2013 41
2014 33
2015 38
2016 35
2017 30
2018 27
2019 16
2020 22
2021 28
2022 31
2023 280
2024 125
2025 55
2026 3
Total 1,097
Download as CSV

Anthony W. Tolcher publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Anthony W. Tolcher sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 681–700 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 699 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336 699
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Anthony W. Tolcher D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Anthony W. Tolcher sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 86–87 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960 86
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Anthony W. Tolcher is affiliated with Texas Oncology in the United States. Their research contributions primarily lie within the fields of Medicine and Biochemistry, Genetics and Molecular Biology. They have a significant focus on oncology and molecular biology with additional expertise covering radiology, nuclear medicine and imaging, immunology, and pulmonary and respiratory medicine.

Their work touches on several specialized subjects including cancer immunotherapy and biomarkers, monoclonal and polyclonal antibodies research, HER2/EGFR in cancer research, CAR-T cell therapy research, cancer research and treatments, peptidase inhibition and analysis, and colorectal cancer treatments and studies.

Frequent collaborators in their research include Alexander I. Spira, Erika Hamilton, Timothy A. Yap, Patricia LoRusso, and Melissa L. Johnson. The scholar has published extensively in respected venues, with notable recurrent publication outlets being:

  • Journal of Clinical Oncology
  • Cancer Research
  • Regular and Young Investigator Award Abstracts
  • Clinical Cancer Research
  • Annals of Oncology

Representative recent papers authored or co-authored by Anthony W. Tolcher include:

  • Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial (2022), Journal for ImmunoTherapy of Cancer
  • First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2-Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non-Small-Cell Lung Cancer: TROPION-PanTumor01 (2023), Journal of Clinical Oncology
  • Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study (2024), Journal of Clinical Oncology
  • First-in-human study of PC14586, a small molecule structural corrector of Y220C mutant p53, in patients with advanced solid tumors harboring a TP53 Y220C mutation. (2022), Journal of Clinical Oncology
  • First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors (2021), Clinical Cancer Research

Best Publications

  • Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

    Mark E. Davis;Jonathan E Zuckerman;Chung Hang J Choi;David Seligson

  • Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies

    Manuel Hidalgo;Lillian L. Siu;John Nemunaitis;Jinee Rizzo

  • First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors

    Timothy A. Yap;Li Yan;Amita Patnaik;Ivy Fearen

  • Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's Lymphoma

    Randy D. Gascoyne;Sheryle A. Adomat;Sheryle A. Adomat;Stanislaw Krajewski;Stanislaw Krajewski;Maryla Krajewska;Maryla Krajewska

  • Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors

    Amita Patnaik;S. Peter Kang;Drew Rasco;Kyriakos P. Papadopoulos

  • Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors

    Amita Patnaik;Lee S. Rosen;Sara M. Tolaney;Anthony W. Tolcher

  • The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer

    Toshio Shimizu;Anthony W. Tolcher;Kyriakos P. Papadopoulos;Muralidhar Beeram

  • Phase I and pharmacokinetic study of XRP6258 (RPR 116258A), a novel taxane, administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumors.

    Alain C. Mita;Louis J. Denis;Eric K. Rowinsky;Johann S. DeBono

  • Phase I Pharmacokinetic and Biologic Correlative Study of Mapatumumab, a Fully Human Monoclonal Antibody With Agonist Activity to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor-1

    Anthony W. Tolcher;Monica Mita;Neal J. Meropol;Margaret von Mehren

  • Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

    A W Tolcher;S L Gerson;L Denis;C Geyer

  • Phase I trial of the novel mammalian target of rapamycin inhibitor deforolimus (AP23573; MK-8669) administered intravenously daily for 5 days every 2 weeks to patients with advanced malignancies.

    Monica M. Mita;Alain C. Mita;Quincy S. Chu;Eric K. Rowinsky

  • Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1

    Anthony W. Tolcher;John Sarantopoulos;Amita Patnaik;Kyriakos Papadopoulos

  • Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA

    Jonathan E. Zuckerman;Ismael Gritli;Anthony Tolcher;Jeremy D. Heidel

  • Randomized Phase II Study of BR96-Doxorubicin Conjugate in Patients With Metastatic Breast Cancer

    Anthony W. Tolcher;Steven Sugarman;Karen A. Gelmon;Roger Cohen

  • First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study

    Ryan J. Sullivan;Jeffrey R. Infante;Filip Janku;Deborah Jean Lee Wong

  • Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin

    Anthony W. Tolcher;Alain Mita;Lionel D. Lewis;Christopher R. Garrett

  • Cantuzumab Mertansine, a Maytansinoid Immunoconjugate Directed to the CanAg Antigen: A Phase I, Pharmacokinetic, and Biologic Correlative Study

    Anthony W. Tolcher;Leonel Ochoa;Lisa A. Hammond;Amita Patnaik

  • Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors

    Anthony W. Tolcher;Wells A. Messersmith;Stanislaw M. Mikulski;Kyriakos P. Papadopoulos

  • Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas

    Sant P. Chawla;Arthur P. Staddon;Laurence H. Baker;Scott M. Schuetze

  • A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors

    Shahneen K. Sandhu;Kyri Papadopoulos;Peter C. Fong;Amita Patnaik

Frequent Co-Authors

Amita Patnaik
Amita Patnaik University of Chicago
Patricia LoRusso
Patricia LoRusso Yale University
Geoffrey I. Shapiro
Geoffrey I. Shapiro Harvard University
Johanna C. Bendell
Johanna C. Bendell Sarah Cannon Research Institute
Johann S. de Bono
Johann S. de Bono Institute of Cancer Research
Keith T. Flaherty
Keith T. Flaherty Harvard University
Jeffrey R. Infante
Jeffrey R. Infante Janssen (Belgium)
Ryan J. Sullivan
Ryan J. Sullivan Harvard University
Howard A. Burris
Howard A. Burris Sarah Cannon Research Institute
George D. Demetri
George D. Demetri Dana-Farber Cancer Institute

External Links

Personal website of Anthony W. Tolcher

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Choosing a career in medicine opens a wide array of academic and professional options beyond traditional MD or DO routes. Today, online education has made it easier than ever for students and professionals to advance or specialize in various healthcare fields.

For registered nurses seeking an advanced practice role, rn to fnp bridge programs offer a streamlined pathway to become a Family Nurse Practitioner. Alternatively, those interested in growing demand within nutrition and wellness might explore best online nutrition programs to step into roles like dietitian or health coach.

Many healthcare professionals view management as a fulfilling next step. Accredited graduate degrees such as online mha programs can prepare you for leadership in hospitals and health systems. For RNs balancing work and education, accelerated rn to bsn online without clinicals options are available, allowing career advancement with maximum flexibility.

Exploring these online degrees expands your potential career pathways, empowering you to shape a future in healthcare that fits your interests and schedule.

Best Scientists Citing Anthony W. Tolcher

Martin E. Gleave

Martin E. Gleave

University of British Columbia

Publications: 81

Johann S. de Bono

Johann S. de Bono

Institute of Cancer Research

Publications: 64

Jos H. Beijnen

Jos H. Beijnen

Utrecht University

Publications: 56

Robert Langer

Robert Langer

MIT

Publications: 47

Jan H.M. Schellens

Jan H.M. Schellens

Utrecht University

Publications: 47

Ernst Wagner

Ernst Wagner

Ludwig-Maximilians-Universität München

Publications: 46

Patricia LoRusso

Patricia LoRusso

Yale University

Publications: 45

Razelle Kurzrock

Razelle Kurzrock

Medical College of Wisconsin

Publications: 42

Manuel Hidalgo

Manuel Hidalgo

Cornell University

Publications: 38

Josep Tabernero

Josep Tabernero

Vall d´Hebron Institute of Oncology

Publications: 38

Daniel G. Anderson

Daniel G. Anderson

MIT

Publications: 37

Omid C. Farokhzad

Omid C. Farokhzad

Harvard Medical School

Publications: 36

José Baselga

José Baselga

Memorial Sloan Kettering Cancer Center

Publications: 34

Fortunato Ciardiello

Fortunato Ciardiello

University of Campania "Luigi Vanvitelli"

Publications: 31

David S. Hong

David S. Hong

The University of Texas MD Anderson Cancer Center

Publications: 31

Filip Janku

Filip Janku

The University of Texas MD Anderson Cancer Center

Publications: 26

Trending Scientists

Zhongbin Zhuang

Zhongbin Zhuang

Beijing University of Chemical Technology

Monique Turmel

Monique Turmel

Université Laval

Susan Carey

Susan Carey

Harvard University

Sari L. Reisner

Sari L. Reisner

University of Michigan–Ann Arbor

Lola L. Cuddy

Lola L. Cuddy

Queen's University

James B. Harsh

James B. Harsh

Washington State University

Rawshan Ara Begum

Rawshan Ara Begum

Western Sydney University

Kevin M. Fitzpatrick

Kevin M. Fitzpatrick

University of Arkansas at Fayetteville

Jian Wang

Jian Wang

Huazhong University of Science and Technology

Antonio M. López

Antonio M. López

Autonomous University of Barcelona

Joshua Rokach

Joshua Rokach

Florida Institute of Technology

Dorrit Posel

Dorrit Posel

University of the Witwatersrand

Aart Kraay

Aart Kraay

World Bank

Heiner C. Bucher

Heiner C. Bucher

University Hospital of Basel

Irving H. Zucker

Irving H. Zucker

University of Nebraska Medical Center

Francisco Javier Salvador

Francisco Javier Salvador

Universitat Politècnica de València

Related Medicine Rankings & Guides

2027 How Much Do Medical Assistant Programs & Certifications Cost?

2027 How Much Do Medical Assistant Programs & Certifications Cost?
2027 Best Online Surgical Tech Certificate Programs

2027 Best Online Surgical Tech Certificate Programs
2027 Fastest Online MSN in Psychiatric Mental Health NP Programs

2027 Fastest Online MSN in Psychiatric Mental Health NP Programs
2027 Most Affordable Master’s Degrees in Healthcare Administration

2027 Most Affordable Master’s Degrees in Healthcare Administration
2027 Best Online DNP Programs

2027 Best Online DNP Programs
2027 Best Online Medical & Healthcare Certificate Programs

2027 Best Online Medical & Healthcare Certificate Programs
2027 Best Nurse Practitioner Programs in Florida – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Florida – Accredited Schools Online & Campus
2027 Best Online CAHME-Accredited MHA Programs

2027 Best Online CAHME-Accredited MHA Programs
2027 Best Nurse Practitioner Programs in Ohio – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Ohio – Accredited Schools Online & Campus
2027 Best Shortest Online Post-Master's FNP Certificate Programs

2027 Best Shortest Online Post-Master's FNP Certificate Programs
2027 Best Online Respiratory Therapy Programs

2027 Best Online Respiratory Therapy Programs
2027 Best Nurse Practitioner Programs in Mississippi – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Mississippi – Accredited Schools Online & Campus
2027 Best Online Nursing Programs in Texas – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Texas – Accredited RN to BSN Programs
2027 Best Online Medical Assistant Associate Degree Programs

2027 Best Online Medical Assistant Associate Degree Programs
2027 Best Nurse Practitioner Programs in Arizona – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Arizona – Accredited Schools Online & Campus
September 2027 Best Nursing Certifications to Consider

September 2027 Best Nursing Certifications to Consider
2027 Best Paramedic-to-RN Bridge Programs

2027 Best Paramedic-to-RN Bridge Programs
2027 Most Affordable Online Health Information Management Degree Programs

2027 Most Affordable Online Health Information Management Degree Programs
2027 Best Online Adult-Gerontology ACNP Graduate Certificate Programs

2027 Best Online Adult-Gerontology ACNP Graduate Certificate Programs
2027 Fastest Online Pharmacy Technician Certificate Programs

2027 Fastest Online Pharmacy Technician Certificate Programs
2027 Best Online Nursing Programs in California: Accredited RN to BSN Programs

2027 Best Online Nursing Programs in California: Accredited RN to BSN Programs

Recently Published Articles

2027 What Can You Do with an Entertainment Business Master's Degree? Careers, Salaries & Growth

2027 What Can You Do with an Entertainment Business Master's Degree? Careers, Salaries & Growth
2027 Career Outcomes for DSW Graduates (Administration, Policy, Academia)

2027 Career Outcomes for DSW Graduates (Administration, Policy, Academia)
2027 How to Compare Fashion Design Degree Programs Effectively

2027 How to Compare Fashion Design Degree Programs Effectively
2027 What Jobs Can You Get With a Graphic Design Bachelor's Degree?

2027 What Jobs Can You Get With a Graphic Design Bachelor's Degree?
2027 Online Hospitality Management & Tourism Bachelor's Degree Programs Under $10,000

2027 Online Hospitality Management & Tourism Bachelor's Degree Programs Under $10,000
2027 Respiratory Care Therapy Clinical Hours Requirements: What Counts and How to Complete Them

2027 Respiratory Care Therapy Clinical Hours Requirements: What Counts and How to Complete Them
2027 Military-Friendly Online Engineering Management Degree Programs: Benefits, Accreditation, and Career Outcomes

2027 Military-Friendly Online Engineering Management Degree Programs: Benefits, Accreditation, and Career Outcomes
2027 What Prerequisites Do You Need for an Accounting Master's Degree? Entry Requirements, Credits & Eligibility Rules

2027 What Prerequisites Do You Need for an Accounting Master's Degree? Entry Requirements, Credits & Eligibility Rules
2027 CACREP Accreditation: Everything You Need to Know

2027 CACREP Accreditation: Everything You Need to Know
2027 How to Become a Licensed Counselor (LPC) in Kansas

2027 How to Become a Licensed Counselor (LPC) in Kansas
2027 How to Become a High School Math Teacher in Colorado

2027 How to Become a High School Math Teacher in Colorado
2027 How to Become a Nurse Practitioner in Columbus, OH: Requirements & Salary

2027 How to Become a Nurse Practitioner in Columbus, OH: Requirements & Salary
2027 How Long Does It Take to Get a Business Degree from Bachelor’s to Doctorate?

2027 How Long Does It Take to Get a Business Degree from Bachelor’s to Doctorate?
2027 Nurse Executive Leadership Degree Master's Programs Accepting Students Now

2027 Nurse Executive Leadership Degree Master's Programs Accepting Students Now
2027 Developmental Psychology Degree vs. Certificate: Which Should You Choose?

2027 Developmental Psychology Degree vs. Certificate: Which Should You Choose?
2027 Cyber Security vs. Artificial Intelligence: Explaining the Difference

2027 Cyber Security vs. Artificial Intelligence: Explaining the Difference
2027 Best Online MBA Programs for Energy and Sustainability Careers

2027 Best Online MBA Programs for Energy and Sustainability Careers
2027 Fastest Online Master’s in Legal Studies Program

2027 Fastest Online Master’s in Legal Studies Program
2027 Online Talent Management Doctorate Programs for Experienced Professionals Without Research Backgrounds

2027 Online Talent Management Doctorate Programs for Experienced Professionals Without Research Backgrounds
2027 Online Biology Degree Programs With No Personal Statement or Admissions Essay Required

2027 Online Biology Degree Programs With No Personal Statement or Admissions Essay Required
2027 Online Special Education Doctorate Programs for Experienced Professionals Without Research Backgrounds

2027 Online Special Education Doctorate Programs for Experienced Professionals Without Research Backgrounds